iSpecimen Inc (NASDAQ: ISPC) Emerges As Guiding Light For Investors

iSpecimen Inc (NASDAQ:ISPC) currently has a daily average trading volume of 4.36M but it saw 1037961 shares traded in last market. With a market cap of 3.65M USD, the company’s current market price of $0.28 came rising about 1.82 while comparing to the previous closing price of $0.27. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.35 and as low as $0.20. In the recent trading on the day, stock has struck highest price mark of $0.2601 while lowest mark touched by it was $0.289.

Taking a look at 20-day trading activity of iSpecimen Inc (ISPC) gives us an average price of $0.2706, while its current price level is -79.32% below from 52-week high level whereas it is 39.43% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3133 while that of 200 days or SMA-200 reads an average of $0.3943. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.73% during that period while stretching the period over a month that increases to 13.04%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.13 which implies that the stock is in neutral territory.

Over the week, ISPC’s stock price is moving 11.60% up while it is -8.67% when we observe its performance for the past one month. Year-to-date it is -44.27% down and over the past year, the stock is showing a downside performance of -78.19%.

The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.23 beat the consensus estimate of -0.35 for the same. In next quarter, company is expected to be making quarterly sales of $2.98M as analysts are expecting the sales for current fiscal year at $11.08M and seeing the company making $12.38M in sales next year. Moreover, analysts are in estimates of $2.95M for current-quarter revenue.

Currently, iSpecimen Inc’s total number of outstanding shares is 13.10M with 21.32% of that held by the insiders while 2.55% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -167.43% and return on equity (ROE) at -98.03%. Stock’s beta reads 1.57. Stock has a price to book (P/B) ratio of 0.60 while price to sale or P/S ratio amounts to 0.35. Its return on asset (ROA) is -69.19% on average.